Piperaquine tetraphosphate tetrahydrate
CAS : 4085-31-8
Ref. 3D-EAA08531
100mg | À demander | ||
250mg | À demander |
Informations sur le produit
- 4,4'-(1,3-Propanediydi-4,1-piper-azinediyl)bis[7-chloroquinoline]
- 4,4'-(Propane-1,3-Diyldipiperazine-4,1-Diyl)Bis(7-Chloroquinoline)
- 4,4'-(Trimethylenedi-4,1-Piperazinediyl)Bis(7-Chloro-Quinoline)
- 4,4′-(1,3-Propanediyldi-4,1-piperazinediyl)bis[7-chloroquinoline]
- 7-Chloro-4-[4-[3-[4-(7-Chloroquinolin-4-Yl)Piperazin-1-Yl]Propyl]Piperazin-1-Yl]Quinoline
- Piperaquine Phosphate
- Piperaquinoline
- Quinoline, 4,4′-(trimethylenedi-4,1-piperazinediyl)bis[7-chloro-
- Quinoline,4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis[7-chloro-
Piperaquine is a 4-aminoquinoline compound that is used to treat malaria. Piperaquine tetraphosphate tetrahydrate (PQTP) is the active form of piperaquine and has been shown to have strong antimicrobial activity against both Gram-positive and Gram-negative bacteria. PQTP inhibits protein synthesis in bacterial cells by binding to the 30S ribosomal subunit, preventing peptide bond formation. The insoluble polymer coating of the microcapsules protects the drug from degradation by digestive enzymes, increasing its absorption and efficacy. PQTP has a pharmacokinetic half-life of approximately 20 hours in humans and can be administered orally or intravenously for treatment of severe malaria. The oral bioavailability of PQTP is around 80%.
Propriétés chimiques
Question d’ordre technique sur : 3D-EAA08531 Piperaquine tetraphosphate tetrahydrate
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages